EXPLANATORY NOTE: [***] INDICATES THE PORTION OF THIS EXHIBIT THAT HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.Consulting Agreement • March 31st, 2022 • AIM ImmunoTech Inc. • Biological products, (no disgnostic substances) • Florida
This Consulting Agreement (the “Agreement”) is made effective as of April 4, 2022 (the “Effective Date”), by and between AIM ImmunoTech Inc., a Delaware corporation, with its principal place of business being 2117 SW Highway 484, Ocala FL 34473 (the “Company”) and Ellen M. Lintal with its principal place of business being [***] (“Consultant”). The Company and Consultant are herein sometimes referred to individually as a “Party” and collectively as the “Parties.”
EXPLANATORY NOTE: [***] INDICATES THE PORTION OF THIS EXHIBIT THAT HAS BEEN OMITTED BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.Consulting Agreement • March 31st, 2022 • AIM ImmunoTech Inc. • Biological products, (no disgnostic substances) • Florida
This Consulting Agreement (the “Agreement”) is made effective as of the date fully executed by both parties (the “Effective Date”), by and between AIM ImmunoTech Inc., a Delaware corporation, with its principal place of business being 2117 SW Highway 484, Ocala FL 34473 (the “Company”) and Foresite Advisors, LLC, a Pennsylvania limited liability corporation, with its principal place of business being [***] (“Foresite”). The Company and Foresite are herein sometimes referred to individually as a “Party” and collectively as the “Parties.”
AGREEMENT OF SALE AND PURCHASE by and between AIM ImmunoTech Inc., as Seller and Acellories, Inc., as Buyer Dated as of: March 3, 2022 For the property: 783 Jersey Avenue, City of New Brunswick, Middlesex County, New Jersey AGREEMENT OF SALE AND PURCHASEAgreement of Sale and Purchase • March 31st, 2022 • AIM ImmunoTech Inc. • Biological products, (no disgnostic substances) • New Jersey
THIS AGREEMENT OF SALE AND PURCHASE (this “Agreement”), dated as of March 3, 2022 (the “Effective Date”), is by and between AIM IMMUNOTECH INC., a Delaware corporation (“Seller”), and ACELLORIES, INC., a New York Corporation (“Buyer”).
